ArticleResearch square2026
Causal effect heterogeneity estimation using summary statistics.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Mendelian randomization (MR) has swiftly gained popularity as a tool for causal inference in genetic epidemiology. However, existing MR methods focus exclusively on estimating the average causal effect and cannot quantify its heterogeneity, posing a major methodological limitation and impeding context-dependent causal findings. Here, we introduce MEndelian Randomization for Linear INteraction (MERLIN), a unified Bayesian framework that jointly estimates the average and context-dependent causal effects using summary data from genome-wide association and interaction studies. Through extensive simulation analyses, we demonstrate the improved power, robustness, and broad utility of MERLIN versus existing methods. We show MERLIN was able to identify sex-specific causal effects of schizophrenia on brain imaging traits, a male-specific causal effect of testosterone on bipolar disorder, and age-dependent causal effects of metabolic biomarkers on coronary artery disease risk. These results illustrate the transformative potential of summary-data-based inference for causal heterogeneity. Together, MERLIN provides a powerful and practical framework for investigating causal effect heterogeneity using summary-level observational data and greatly enhances our capability to elucidate complex disease etiology.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.